Evidence map›Paper›PMID 38935528›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2024

PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial Cells

David Kleinman, Sana Iqbal, Anita K Ghosh, Sean D Ogle, Simon Kaja, Mark Mitchnick, Jenni J Hakkarainen

Abstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

David KleinmanCalm Water Therapeutics LLC, Rochester, New York, USA.ORCID 0000-0002-1311-5216
Sana IqbalGraduate Program in Molecular Pharmacology and Therapeutics, Health Sciences Division, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0009-0005-6191-0539
Anita K GhoshDepartment of Ophthalmology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.
Sean D OgleResearch & Development Division, Experimentica Ltd, Forest Park, Illinois, USA.
Simon KajaDepartment of Molecular Pharmacology & Neuroscience, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois, USA.ORCID 0000-0001-6878-521X
Mark MitchnickCalm Water Therapeutics LLC, Rochester, New York, USA.
Jenni J HakkarainenResearch & Development Division, Experimentica Ltd, Kuopio, Finland.ORCID 0000-0002-2528-7525

Funding

Immunotherapy for Ocular Surface DiseasesR24EY032440 · NEI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI JAIN, SANDEEP · 2021 to 2025
$8.3M
NEI NIH HHS R24 EY032440
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Epithelium, CornealImmunoconjugatesPolyethylene GlycolsAmilorideCell ProliferationCells, CulturedEpithelial CellsHumansOligopeptidesPinocytosisPolylysinePolymersAmilorideethylisopropylamilorideImmunoconjugatesmonomethylauristatin FOligopeptidesPolyethylene GlycolsPolylysinePolymersantibody-drug conjugatecorneamacropinocytosisocular surface disease

Identifiers

PMID38935528
PMCPMC11564684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.